Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women

Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women

10.1016/j.phymed.2021.153680

Saved in:
Bibliographic Details
Main Authors: Yong, E.L., Cheong W.-F., Huang, Zhongwei, WIN PA PA THU, ANGELICA, AMAURY CAZENAVE GASSIOT, KOK YONG SENG, LOGAN SUSAN JANE SINCLAIR
Other Authors: BIOCHEMISTRY
Format: Article
Language:English
Published: ELSEVIER GMBH 2021
Subjects:
Science & Technology
Life Sciences & Biomedicine
Plant Sciences
Chemistry, Medicinal
Integrative & Complementary Medicine
Pharmacology & Pharmacy
Epimedium
Postmenopausal women
Safety
Pharmacokinetics
Bone turnover markers
TRAF6
BIOCHEMICAL MARKERS
HERBA-EPIMEDII
OSTEOPOROSIS
FLAVONOIDS
TURNOVER
PROLIFERATION
ADIPOGENESIS
METABOLISM
GUIDELINES
ICARIIN
Online Access:https://scholarbank.nus.edu.sg/handle/10635/205952
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/205952

Similar Items